Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The troponin-tropomyosin complex is a multi-protein regulatory system critical for the control of muscle contraction in cardiac and skeletal muscle (but not smooth muscle). It is composed of two distinct elements: troponin, a complex containing three subunits (troponin C, I, and T), and tropomyosin, a long, coiled-coil protein that winds along actin filaments in the thin filament of muscle fibers. In a resting muscle at low cytosolic Ca^2+, troponin stabilizes tropomyosin in a position that blocks myosin-binding sites on actin, thereby preventing contraction. Upon calcium ion binding to troponin C, conformational shifts within the troponin complex induce tropomyosin to roll away from actin’s myosin-binding sites, allowing cross-bridging between actin and myosin, leading to muscle contraction. The complex does not function as a receptor, enzyme, transporter, or canonical drug target, but is essential for physiological regulation of muscle activity and serves as an important diagnostic biomarker for cardiac injury. The phrase "Troponin tropomyosin complex" refers to a multi-protein regulatory complex, not a discrete molecule or canonical drug target. It is not a receptor, enzyme, transporter, or other canonical single-protein target as typically considered in drug discovery or pharmacology. While its subunits (particularly cardiac troponins) have enormous diagnostic importance, the complex itself is not directly targeted by approved drugs. Aliases often refer to the individual protein subunits or the thin filament regulatory apparatus rather than a singular "target" entity. The troponin-tropomyosin complex is not a canonical therapeutic target and therefore many fields (drugs, mechanism) do not apply. Cardiac troponin is a validated biomarker, but the complex itself should not be considered for "is_target" except in the context of physiological understanding or rare research settings. The query appears somewhat incorrect for drug-target purposes; this is a regulatory protein complex, not a canonical target or molecule.
Not applicable; the complex is not considered a direct therapeutic target, and there are no drugs with specific mechanisms of action targeting the troponin-tropomyosin complex.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Troponin-tropomyosin complex (Troponin-TM complex).